About
Respinor develops DXT, a non-invasive ultrasound-based medical device for continuous diaphragm monitoring to aid early detection of diaphragm dysfunction and improve critical care outcomes in mechanically ventilated patients.
Explore Respinor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.